ANTIBODY FORMULATIONS
PROBLEM TO BE SOLVED: To provide a formulation that retards degradation of an antibody product in the formulation.SOLUTION: The present invention provides antibody formulations, including monoclonal antibodies formulated in a histidine-acetate buffer, and a formulation comprising an antibody that bi...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English |
Published |
04.09.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | PROBLEM TO BE SOLVED: To provide a formulation that retards degradation of an antibody product in the formulation.SOLUTION: The present invention provides antibody formulations, including monoclonal antibodies formulated in a histidine-acetate buffer, and a formulation comprising an antibody that binds to domain II of HER2 (for example, Pertuzumab), and a formulation comprising an antibody that binds to DR5 (for example, Apomab). |
---|---|
AbstractList | PROBLEM TO BE SOLVED: To provide a formulation that retards degradation of an antibody product in the formulation.SOLUTION: The present invention provides antibody formulations, including monoclonal antibodies formulated in a histidine-acetate buffer, and a formulation comprising an antibody that binds to domain II of HER2 (for example, Pertuzumab), and a formulation comprising an antibody that binds to DR5 (for example, Apomab). |
Author | LIU JUN GWEE SHIANG C SHEN YE ANDYA JAMES D |
Author_xml | – fullname: ANDYA JAMES D – fullname: LIU JUN – fullname: SHEN YE – fullname: GWEE SHIANG C |
BookMark | eNrjYmDJy89L5WQQdfQL8XTyd4lUcPMP8g31cQzx9PcL5mFgTUvMKU7lhdLcDEpuriHOHrqpBfnxqcUFicmpeakl8V4BRgaGJoamliZmlo7GRCkCALb0IV0 |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | JP2014159469A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_JP2014159469A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:27:22 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_JP2014159469A3 |
Notes | Application Number: JP20140097390 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140904&DB=EPODOC&CC=JP&NR=2014159469A |
ParticipantIDs | epo_espacenet_JP2014159469A |
PublicationCentury | 2000 |
PublicationDate | 20140904 |
PublicationDateYYYYMMDD | 2014-09-04 |
PublicationDate_xml | – month: 09 year: 2014 text: 20140904 day: 04 |
PublicationDecade | 2010 |
PublicationYear | 2014 |
RelatedCompanies | GENENTECH INC |
RelatedCompanies_xml | – name: GENENTECH INC |
Score | 2.9467661 |
Snippet | PROBLEM TO BE SOLVED: To provide a formulation that retards degradation of an antibody product in the formulation.SOLUTION: The present invention provides... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | ANTIBODY FORMULATIONS |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140904&DB=EPODOC&locale=&CC=JP&NR=2014159469A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMUs1SjY3TDHUtUhMNNU1SUlK1bUwSTbTBU25JZoYp1gYmoM2OPv6mXmEmnhFmEYwMWTD9sKAzwktBx-OCMxRycD8XgIurwsQg1gu4LWVxfpJmUChfHu3EFsXNWjvGHR6EzDSXZxsXQP8Xfyd1Zydbb0C1PyCwHLAmhvYGXRkZmAFtqPNwb22MCfQtpQC5DrFTZCBLQBoXF6JEANTap4wA6cz7Oo1YQYOX-iMN5AJzXzFIgyijn4hnk7-LpEKwJ6bb6gPZAewKIOSm2uIs4cu0Px4uG_ivQKQ3GIsxsAC7OanSjAopAArXoNUc1NgFZtoYpCclARseSVZGKUYGqVZpgGxJIM0HoOk8MpKM3CBeOC1USYyDCwlRaWpssDKtCRJDhwIAOLVdLM |
link.rule.ids | 230,309,783,888,25577,76883 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMUs1SjY3TDHUtUhMNNU1SUlK1bUwSTbTBU25JZoYp1gYmoM2OPv6mXmEmnhFmEYwMWTD9sKAzwktBx-OCMxRycD8XgIurwsQg1gu4LWVxfpJmUChfHu3EFsXNWjvGHR6EzDSXZxsXQP8Xfyd1Zydbb0C1PyCwHLAmhvYGXRkZmAFtrEtwH2lMCfQtpQC5DrFTZCBLQBoXF6JEANTap4wA6cz7Oo1YQYOX-iMN5AJzXzFIgyijn4hnk7-LpEKwJ6bb6gPZAewKIOSm2uIs4cu0Px4uG_ivQKQ3GIsxsAC7OanSjAopAArXoNUc1NgFZtoYpCclARseSVZGKUYGqVZpgGxJIM0HoOk8MrKM3B6hPj6xPt4-nlLM3CBZMDrpExkGFhKikpTZYEVa0mSHDhAAILXd6M |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=ANTIBODY+FORMULATIONS&rft.inventor=ANDYA+JAMES+D&rft.inventor=LIU+JUN&rft.inventor=SHEN+YE&rft.inventor=GWEE+SHIANG+C&rft.date=2014-09-04&rft.externalDBID=A&rft.externalDocID=JP2014159469A |